中國批准全球首個侵入式腦機接口——為何不是Neuralink？
中國國家藥監局批准了Neuracle的NEO腦植入物用於脊髓損傷患者，擊敗Neuralink成為首個獲准上市的侵入式腦機接口。
china approved the neo device, developed by neuracle technology and tsinghua university, for patients with quadriplegia due to spinal cord injuries, marking the first regulatory green light for an invasive bci globally. the system uses sensors placed on the brain's outer membrane to interpret signals and drive external robotics, offering a safer profile than neuralink's penetrating threads by reducing hemorrhage risk. this milestone highlights china's accelerated regulatory pathway for neurotech, granting it a first-mover advantage in the commercial bci market ahead of us competitors.